MedImmune

antibody-based therapeutics

History:

MedImmune was acquired by AstraZeneca in 2007. AstraZeneca then combined Cambridge Antibody Technology (a previous acquisition) under the MedImmune name.

Employment

Email:

Fax:

Mail:

General Info:

Ticker: MEDI

Employees:

Regions:
Northeast

Research Focus:
Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: